The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global Antibody market was valued at US$ 9091 million in 2023 and is anticipated to reach US$ 13110 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
This report aims to provide a comprehensive presentation of the global market for Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody.
Report Scope
The Antibody market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Segment by Type
IgM
IgG
IgA
Other
Segment by Application
Therapeutic
Research
Diagnostic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens”). The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
The global Antibody market was valued at US$ 9091 million in 2023 and is anticipated to reach US$ 13110 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Global Monoclonal Antibodies key players include Roche, Johnson and Johnson, Merck, Novartis, AbbVie, etc. Global top five players hold a share about 35%.
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, having a total share about 45 percent.
In terms of product, IgG is the largest segment, with a share about 80%. And in terms of application, the largest application is Research, followed by Therapeutic and Diagnostic.
This report aims to provide a comprehensive presentation of the global market for Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody.
Report Scope
The Antibody market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Roche
Johnson and Johnson
Merck
Novartis
AbbVie
Amgen
Pfizer
Bayer
Lilly
Bristol-Myers Squibb
GlaxoSmithKline
Biogen
AstraZeneca
Sanofi
Alexion Pharmaceuticals
Seattle Genetics
Segment by Type
IgM
IgG
IgA
Other
Segment by Application
Therapeutic
Research
Diagnostic
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Antibody Market Overview
1.1 Product Overview and Scope of Antibody
1.2 Antibody Segment by Type
1.2.1 Global Antibody Market Value Comparison by Type (2024-2030)
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.2.5 Other
1.3 Antibody Segment by Application
1.3.1 Global Antibody Market Value by Application: (2024-2030)
1.3.2 Therapeutic
1.3.3 Research
1.3.4 Diagnostic
1.4 Global Antibody Market Size Estimates and Forecasts
1.4.1 Global Antibody Revenue 2019-2030
1.4.2 Global Antibody Sales 2019-2030
1.4.3 Global Antibody Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antibody Market Competition by Manufacturers
2.1 Global Antibody Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antibody Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antibody Average Price by Manufacturers (2019-2024)
2.4 Global Antibody Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antibody, Product Type & Application
2.7 Antibody Market Competitive Situation and Trends
2.7.1 Antibody Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antibody Players Market Share by Revenue
2.7.3 Global Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antibody Retrospective Market Scenario by Region
3.1 Global Antibody Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antibody Global Antibody Sales by Region: 2019-2030
3.2.1 Global Antibody Sales by Region: 2019-2024
3.2.2 Global Antibody Sales by Region: 2025-2030
3.3 Global Antibody Global Antibody Revenue by Region: 2019-2030
3.3.1 Global Antibody Revenue by Region: 2019-2024
3.3.2 Global Antibody Revenue by Region: 2025-2030
3.4 North America Antibody Market Facts & Figures by Country
3.4.1 North America Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antibody Sales by Country (2019-2030)
3.4.3 North America Antibody Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antibody Market Facts & Figures by Country
3.5.1 Europe Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antibody Sales by Country (2019-2030)
3.5.3 Europe Antibody Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antibody Market Facts & Figures by Country
3.6.1 Asia Pacific Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antibody Sales by Country (2019-2030)
3.6.3 Asia Pacific Antibody Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Antibody Market Facts & Figures by Country
3.7.1 Latin America Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antibody Sales by Country (2019-2030)
3.7.3 Latin America Antibody Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Antibody Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antibody Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antibody Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antibody Sales by Type (2019-2030)
4.1.1 Global Antibody Sales by Type (2019-2024)
4.1.2 Global Antibody Sales by Type (2025-2030)
4.1.3 Global Antibody Sales Market Share by Type (2019-2030)
4.2 Global Antibody Revenue by Type (2019-2030)
4.2.1 Global Antibody Revenue by Type (2019-2024)
4.2.2 Global Antibody Revenue by Type (2025-2030)
4.2.3 Global Antibody Revenue Market Share by Type (2019-2030)
4.3 Global Antibody Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antibody Sales by Application (2019-2030)
5.1.1 Global Antibody Sales by Application (2019-2024)
5.1.2 Global Antibody Sales by Application (2025-2030)
5.1.3 Global Antibody Sales Market Share by Application (2019-2030)
5.2 Global Antibody Revenue by Application (2019-2030)
5.2.1 Global Antibody Revenue by Application (2019-2024)
5.2.2 Global Antibody Revenue by Application (2025-2030)
5.2.3 Global Antibody Revenue Market Share by Application (2019-2030)
5.3 Global Antibody Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Antibody Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Roche Antibody Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Description and Business Overview
6.2.3 Johnson and Johnson Antibody Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson and Johnson Antibody Product Portfolio
6.2.5 Johnson and Johnson Recent Developments/Updates
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Antibody Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Merck Antibody Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Antibody Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 AbbVie
6.5.1 AbbVie Corporation Information
6.5.2 AbbVie Description and Business Overview
6.5.3 AbbVie Antibody Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AbbVie Antibody Product Portfolio
6.5.5 AbbVie Recent Developments/Updates
6.6 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Antibody Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Amgen Antibody Product Portfolio
6.6.5 Amgen Recent Developments/Updates
6.7 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Antibody Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pfizer Antibody Product Portfolio
6.7.5 Pfizer Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Corporation Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Antibody Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bayer Antibody Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Antibody Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Lilly Antibody Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Bristol-Myers Squibb
6.10.1 Bristol-Myers Squibb Corporation Information
6.10.2 Bristol-Myers Squibb Description and Business Overview
6.10.3 Bristol-Myers Squibb Antibody Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bristol-Myers Squibb Antibody Product Portfolio
6.10.5 Bristol-Myers Squibb Recent Developments/Updates
6.11 GlaxoSmithKline
6.11.1 GlaxoSmithKline Corporation Information
6.11.2 GlaxoSmithKline Antibody Description and Business Overview
6.11.3 GlaxoSmithKline Antibody Sales, Revenue and Gross Margin (2019-2024)
6.11.4 GlaxoSmithKline Antibody Product Portfolio
6.11.5 GlaxoSmithKline Recent Developments/Updates
6.12 Biogen
6.12.1 Biogen Corporation Information
6.12.2 Biogen Antibody Description and Business Overview
6.12.3 Biogen Antibody Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Biogen Antibody Product Portfolio
6.12.5 Biogen Recent Developments/Updates
6.13 AstraZeneca
6.13.1 AstraZeneca Corporation Information
6.13.2 AstraZeneca Antibody Description and Business Overview
6.13.3 AstraZeneca Antibody Sales, Revenue and Gross Margin (2019-2024)
6.13.4 AstraZeneca Antibody Product Portfolio
6.13.5 AstraZeneca Recent Developments/Updates
6.14 Sanofi
6.14.1 Sanofi Corporation Information
6.14.2 Sanofi Antibody Description and Business Overview
6.14.3 Sanofi Antibody Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sanofi Antibody Product Portfolio
6.14.5 Sanofi Recent Developments/Updates
6.15 Alexion Pharmaceuticals
6.15.1 Alexion Pharmaceuticals Corporation Information
6.15.2 Alexion Pharmaceuticals Antibody Description and Business Overview
6.15.3 Alexion Pharmaceuticals Antibody Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Alexion Pharmaceuticals Antibody Product Portfolio
6.15.5 Alexion Pharmaceuticals Recent Developments/Updates
6.16 Seattle Genetics
6.16.1 Seattle Genetics Corporation Information
6.16.2 Seattle Genetics Antibody Description and Business Overview
6.16.3 Seattle Genetics Antibody Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Seattle Genetics Antibody Product Portfolio
6.16.5 Seattle Genetics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antibody Industry Chain Analysis
7.2 Antibody Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antibody Production Mode & Process
7.4 Antibody Sales and Marketing
7.4.1 Antibody Sales Channels
7.4.2 Antibody Distributors
7.5 Antibody Customers
8 Antibody Market Dynamics
8.1 Antibody Industry Trends
8.2 Antibody Market Drivers
8.3 Antibody Market Challenges
8.4 Antibody Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
